Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors

A global view of the interplay between non-alcoholic fatty liver disease and diabetes

(2022) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals

(2022) Jingxuan Quek et al.   Endocrine Practice

Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals

(2022) Kai En Chan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients

(2022) Gwyneth Kong et al.   Frontiers in Cardiovascular Medicine

Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update

(2022) Nicholas Chew et al.   SEMINARS IN LIVER DISEASE

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review

(2021) Luca Rinaldi et al.   Antioxidants

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

(2021) Ferdinando Carlo Sasso et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

(2020) Luigi Elio Adinolfi et al.   ATHEROSCLEROSIS

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

(2020) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Causes, consequences, and treatment of metabolically unhealthy fat distribution

(2020) Norbert Stefan   Lancet Diabetes & Endocrinology

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?

(2019) Stephen T. Vernon et al.   Journal of the American Heart Association

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

(2017) Cristina Alonso et al.   GASTROENTEROLOGY

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE